✕
Login
Register
Back to News
BTIG Reiterates Buy on Nurix Therapeutics, Maintains $30 Price Target
Benzinga Newsdesk
www.benzinga.com
Neutral 92.4%
Neg 0%
Neu 92.4%
Pos 0%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment